Galera Therapeutics Inc. (GRTX)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Revenue	-	-	-	-	-	-	-
Cost of Revenue	259.00K	114.00K	778.00K	368.00K	267.00K	127.00K	84.00K
Gross Profit	-259.00K	-114.00K	-778.00K	-368.00K	-267.00K	-127.00K	-84.00K
Operating Income	-46.95M	-51.23M	-73.37M	-70.55M	-50.69M	-24.25M	-24.09M
Interest Income	9.82M	506.00K	32.00K	1.17M	1.82M	606.00K	193.00K
Pretax Income	-59.08M	-62.29M	-80.53M	-74.23M	-51.94M	-23.90M	-23.91M
Net Income	-59.08M	-62.22M	-87.73M	-74.22M	-51.93M	-23.68M	-23.55M
Selling & General & Admin	22.84M	20.21M	20.95M	15.71M	8.36M	5.59M	3.50M
Research & Development	24.11M	31.01M	52.42M	54.84M	42.33M	18.66M	20.59M
Other Expenses	-	-11.07M	-7.17M	-3.68M	-1.25M	-	-
Operating Expenses	46.95M	51.23M	73.37M	70.55M	50.69M	24.25M	24.09M
Interest Expense	-	11.57M	7.19M	4.88M	3.03M	220.00K	-
Selling & Marketing Expenses	-	-	-	-	-	-	-
Cost & Expenses	46.95M	51.23M	73.37M	70.55M	50.69M	24.25M	24.09M
Income Tax	-	-70.00K	7.19M	-16.00K	-9.00K	-223.00K	-360.00K
Shares Outstanding (Basic)	44.55M	27.09M	25.79M	24.87M	24.81M	19.36M	15.22M
Shares Outstanding (Diluted)	44.55M	27.09M	25.79M	24.87M	24.81M	19.36M	15.22M
EPS (Basic)	-1.33	-2.3	-3.4	-2.98	-2.09	-1.22	-1.55
EPS (Diluted)	-1.33	-2.3	-3.4	-2.98	-2.09	-1.22	-1.55
EBITDA	-46.69M	-50.61M	-72.56M	-69.01M	-50.69M	-23.52M	-23.82M
Depreciation & Amortization	259.00K	114.00K	778.00K	368.00K	267.00K	127.00K	84.00K